Mustafa Altınbaş - Concepedia

Author

Mustafa Altınbaş

Also Known As

M Altinbas, M Altınbaş, M. ALTINBAŞ, M. Altinbas, MUSTAFA ALTINBAS, Mustafa ALTINBAS, Mustafa ALTINBAŞ, Mustafa Altinbas, Mustafa Altinbaş, Mustafa Altınbaş

115

Publications

968

Citations

H-Index

Concepts

All Affiliations

Erciyes University Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi Memorial Ankara Hospital Ankara University Gaziantep University

About

Mustafa Altınbaş is an author at Erciyes University specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	121
2	Health Sciences	2	2	50
3	Cell Biology	1	1	14
4	Diabetes	1	1	16
5	Gastroenterology	1	1	16

Mustafa Altınbaş

Publications

326

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and Safety of the Coronavac Vaccine in Patients with Cancer Receiving Active Systemic Therapy Cengiz Karaçin, Tülay Eren, Esra Zeynelgil, Future Oncology	2021	39
Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma Deniz Demirci, Ali Ünal, Mustafa Altınbaş, Human & Experimental Toxicology Liver Function TestsPharmacotherapyToxicologyHepatotoxicityRadiation Oncology	1999	37
Factors Related to Complementary/Alternative Medicine use among Cancer Patients in Central Anatolia Özlem Er, Metin Özkan, Ahmet Öztürk, Tumori Journal	2008	27
Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer Yakup Düzköprü, Abdülkadir Koçanoğlu, Özlem Doğan, World Journal of Gastrointestinal Oncology	2023	25
Rapidly Relapsing Squamous Cell Carcinoma of the Renal Pelvis Associated with Paraneoplastic Syndromes of Leukocytosis, Thrombocytosis and Hypercalcemia Özlem Er, Hasan Şenol Çoşkun, Mustafa Altınbaş, Urologia Internationalis UrologyTumoral PathologyGenitourinary CancerSquamous Cell CarcinomaMedicine	2001	24
Irinotecan as a second-line monotherapy for small cell lung cancer. Alper Sevinç, Mehmet Kalender, Mustafa Altınbaş, PubMed	2011	24
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy Cengiz Karaçin, Berna Öksüzoğlu, Ayşe Demirci, BMC Cancer	2023	23
Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer. Metin Özkan, Mustafa Dikilitaş, Gamze Gököz Doğu, PubMed	2010	20
Inhibition of angiogenesis: Thalidomide or low-molecular-weight heparin? Authors' reply Metin Özkan, Bülent Eser, Özlem Er, Journal of Clinical Oncology ThrombosisAngiogenesisHematologyPharmacologyHemostasis	2005	17
High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey Ramiz Çolak, Fahrı Bayram, Mustafa Altınbaş, Diabetes Research and Clinical Practice Pancreatic CancerGlobal HealthDiabetesGastroenterologyHigh Prevalence	2002	16

Page 1